Carl Eibl is a Venture Partner at Anzu Partners. He served from 2003 through 2015 as a Managing Partner at Enterprise Partners, a San Diego-based venture capital firm.  Carl led numerous tech investments in materials, software & analytics and semiconductor related businesses. The firm completed the sale of its remaining portfolio companies and ended in 2015.

Carl is an active investor in a few early-stage high tech companies where he works with the management teams to develop and grow the businesses.    Prior to joining Enterprise, Carl was the CEO of several technology and life science companies, including: Maxwell Technologies (MXWL, NASDAQ), a manufacturer of energy storage devices and radiation-shielded electronics; Stratagene Corporation, a biotechnology company that commercialized DNA sequencing and analytics instruments and reagents. Agilent purchased the company; and Mycogen Corporation, a publicly-held agricultural, bio-technology company, acquired by Dow Chemical Company.

Carl is a former Chairman of The Sanford Burnham Prebys Medical Discovery Institute and a former Vice Chairman of the board of CONNECT www.Connect.org. He has been a member of the San Diego Coastal Chapter of the Young Presidents Organization (YPO) since 1994.

Carl holds a J.D. from Boston University School of Law and a B.A. from Cornell University.